Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2023-04-27 | 2023-07-07 | 190856 |
| APO-PROPAFENONE | 300MG | TABLET TABLET | Resolved | 2023-05-06 | 2023-07-07 | 191871 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-27 | 2018-08-30 | 23632 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2022-02-11 | 2022-03-25 | 154765 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223049 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-09-17 | 2020-10-05 | 124356 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2021-04-23 | 2021-05-31 | 137968 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2023-10-06 | 2023-12-01 | 206557 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209922 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2024-07-25 | 2024-08-09 | 233700 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2020-09-22 | 2020-11-27 | 124795 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2021-03-19 | 2021-04-19 | 136044 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2022-07-15 | 2022-12-16 | 164749 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2022-08-26 | 2022-12-16 | 168047 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2024-02-16 | 2024-03-29 | 219834 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2017-05-02 | 2017-06-27 | 8702 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2017-05-04 | 2017-07-04 | 8883 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-07-31 | 2018-09-28 | 56989 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2021-04-30 | 2021-05-31 | 138352 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2021-05-14 | 2021-05-31 | 139416 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-27 | 247469 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 75MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-10 | 247472 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247466 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247462 |